Sean P. Tully
2017
In 2017, Sean P. Tully earned a total compensation of $2.7M as Global Head of Financial and OTC Products at CME Group, a 3% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $33,094 |
|---|---|
| Non-Equity Incentive Plan | $594,431 |
| Salary | $450,000 |
| Stock Awards | $1,533,699 |
| Other | $75,450 |
| Total | $2,686,674 |
Tully received $1.5M in stock awards, accounting for 57% of the total pay in 2017.
Tully also received $33.1K of change in pension value and nonqualified deferred compensation earnings, $594.4K in non-equity incentive plan, $450K in salary and $75.5K in other compensation.
Rankings
In 2017, Sean P. Tully's compensation ranked 4,113th out of 14,666 executives tracked by ExecPay. In other words, Tully earned more than 72.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,113 out of 14,666 | 72nd |
Division Finance, Insurance, And Real Estate | 798 out of 3,159 | 75th |
Major group Security And Commodity Brokers, Dealers, Exchanges, And Services | 133 out of 259 | 49th |
Source: SEC filing on March 20, 2018.
Tully's colleagues
We found five more compensation records of executives who worked with Sean P. Tully at CME Group in 2017.